Regent Peak Wealth Advisors LLC Moderna, Inc. Transaction History

Regent Peak Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $313,212 - $511,123	-1,387 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $55,918 - $122,086	252 Added 22.2%	1,387 $534,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $147,447 - $266,702	1,135 New	1,135 $401,000
Q1 2021 Apr 28, 2021	SELL	$109.18 - $185.98 $122,609 - $208,855	-1,123 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $73,826 - $190,752	1,123 New	1,123 $117,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.